A detailed history of Hcr Wealth Advisors transactions in Zoetis Inc. stock. As of the latest transaction made, Hcr Wealth Advisors holds 15,470 shares of ZTS stock, worth $2.55 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
15,470
Previous 13,428 15.21%
Holding current value
$2.55 Million
Previous $2.33 Million 29.87%
% of portfolio
0.4%
Previous 0.33%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$172.58 - $196.48 $352,408 - $401,212
2,042 Added 15.21%
15,470 $3.02 Million
Q2 2024

Aug 06, 2024

SELL
$145.54 - $178.83 $42,643 - $52,397
-293 Reduced 2.14%
13,428 $2.33 Million
Q1 2024

May 10, 2024

BUY
$165.67 - $199.94 $28,163 - $33,989
170 Added 1.25%
13,721 $2.32 Million
Q4 2023

Feb 09, 2024

BUY
$151.44 - $200.09 $449,322 - $593,667
2,967 Added 28.03%
13,551 $2.67 Million
Q3 2023

Oct 20, 2023

SELL
$167.14 - $192.77 $223,299 - $257,540
-1,336 Reduced 11.21%
10,584 $1.84 Million
Q2 2023

Aug 09, 2023

BUY
$160.94 - $186.23 $130,522 - $151,032
811 Added 7.3%
11,920 $2.05 Million
Q1 2023

May 12, 2023

BUY
$145.48 - $175.02 $42,771 - $51,455
294 Added 2.72%
11,109 $1.85 Million
Q4 2022

Feb 13, 2023

SELL
$131.14 - $157.47 $125,369 - $150,541
-956 Reduced 8.12%
10,815 $1.59 Million
Q3 2022

Nov 07, 2022

SELL
$148.29 - $182.55 $21,650 - $26,652
-146 Reduced 1.23%
11,771 $1.75 Million
Q2 2022

Aug 12, 2022

SELL
$155.97 - $200.09 $5,770 - $7,403
-37 Reduced 0.31%
11,917 $2.05 Million
Q1 2022

May 05, 2022

BUY
$181.39 - $234.03 $17,957 - $23,168
99 Added 0.84%
11,954 $2.25 Million
Q4 2021

Feb 04, 2022

SELL
$193.69 - $247.03 $83,674 - $106,716
-432 Reduced 3.52%
11,855 $2.89 Million
Q3 2021

Nov 02, 2021

BUY
$189.29 - $209.69 $128,149 - $141,960
677 Added 5.83%
12,287 $2.39 Million
Q2 2021

Jul 21, 2021

BUY
$155.9 - $187.99 $113,962 - $137,420
731 Added 6.72%
11,610 $2.16 Million
Q1 2021

May 13, 2021

BUY
$144.0 - $169.39 $87,696 - $103,158
609 Added 5.93%
10,879 $1.71 Million
Q4 2020

Feb 04, 2021

BUY
$157.07 - $174.35 $153,300 - $170,165
976 Added 10.5%
10,270 $1.7 Million
Q3 2020

Nov 05, 2020

BUY
$137.1 - $165.37 $63,066 - $76,070
460 Added 5.21%
9,294 $1.54 Million
Q2 2020

Jul 30, 2020

SELL
$111.92 - $142.53 $28,875 - $36,772
-258 Reduced 2.84%
8,834 $1.21 Million
Q1 2020

May 08, 2020

SELL
$92.66 - $144.94 $11,489 - $17,972
-124 Reduced 1.35%
9,092 $1.07 Million
Q4 2019

Feb 07, 2020

BUY
$116.25 - $133.25 $52,312 - $59,962
450 Added 5.13%
9,216 $1.22 Million
Q3 2019

Nov 07, 2019

BUY
$112.57 - $128.43 $79,586 - $90,800
707 Added 8.77%
8,766 $1.09 Million
Q2 2019

Jul 25, 2019

BUY
$97.98 - $114.28 $5,682 - $6,628
58 Added 0.72%
8,059 $915,000
Q1 2019

May 10, 2019

SELL
$81.56 - $100.67 $9,868 - $12,181
-121 Reduced 1.49%
8,001 $805,000
Q4 2018

Jan 31, 2019

BUY
$79.28 - $95.27 $215,800 - $259,324
2,722 Added 50.41%
8,122 $695,000
Q3 2018

Nov 09, 2018

BUY
$83.5 - $93.23 $243,820 - $272,231
2,920 Added 117.74%
5,400 $494,000
Q2 2018

Aug 14, 2018

BUY
$79.9 - $89.2 $198,152 - $221,216
2,480 New
2,480 $211,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $77.1B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Hcr Wealth Advisors Portfolio

Follow Hcr Wealth Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hcr Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Hcr Wealth Advisors with notifications on news.